تغییر بیان ژن SHIP2 (SH2 domain containing inositol 5-phosphatase) با استفاده از سیستم رتروویروس در سلول های کبدی HepG2

Authors

  • مشکانی, رضا دانشگاه علوم پزشکی تهران
  • گرگانی فیروزجایی, ستار دانشگاه علوم پزشکی ارتش
Abstract:

Introduction: Dyslypydmy is one of the risk factors of cardiovascular disease in diabetics. Dyslypydmy is diagnosed by increasing in plasma triglyceride density, decreasing HDL Cholesterol, and increasing LDL especially small LDL. Several evidences from human and animal studies indicate that the role of insulin resistance is a major cause of hypertrigly ceridemia in diabetics and people with metabolic syndrome, respectively. Hepatic lipogenesis and the production of rich lipoproteins from triglyceride are set by the inositol phosphatidylinositol kinase (PI3K). However, the negative regulator of route SHIP2 is not well defined in this process (hepatic lipogenesis). Materials and Methods: In this study, the gene expression SHIP2 has been modified by the retroviruses system and the function of intracellular insulin signaling has been studied. Findings: The results show that increasing in expression SHIP2 is lead to decreasing in AKT phosphorylation as one of the mediators of insulin signaling in addition, reducing performance of SHIP2 increase the AKT phosphorylation and improves the intracellular insulin signaling in the liver cells Hep G2. Discussion and Conclusion: Based on the key role AKT phosphorylation in glucose metabolism and lipid, cell models produced can be used in the studies of metabolism of lipids and lipoproteins.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

تغییر بیان ژن ship۲ (sh۲ domain containing inositol ۵-phosphatase) با استفاده از سیستم رتروویروس در سلول های کبدی hepg۲

مقدمه: دیس­لیپیدمی به عنوان یکی از فاکتورهای خطر بیماریهای قلبی عروقی در افراد دیابتی مطرح می­باشد. دیس­لیپیدمی به وسیله افزایش غلظت تریگلیسرید پلاسما، کاهش hdl کلسترول و افزایش ldl به خصوص small dense ldl تشخیص داده می­شود. شواهد متعدد از مطالعات انسانی و حیوانی بیانگر نقش مقاومت به انسولین به عنوان علت اصلی افزایش تریگلیسرید در بیماران دیابتی و افراد مبتلا به سندرم متابولیک می­باشد. لیپوژنز ک...

full text

Evidence for SH2 Domain-Containing 5′-Inositol Phosphatase-2 (SHIP2) Contributing to a Lymphatic Dysfunction

The lymphatic vasculature plays a critical role in a number of disease conditions of increasing prevalence, such as autoimmune disorders, obesity, blood vascular diseases, and cancer metastases. Yet, unlike the blood vasculature, the tools available to interrogate the molecular basis of lymphatic dysfunction/disease have been lacking. More recently, investigators have reported that dysregulatio...

full text

Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.

Many tumors present with increased activation of the phosphatidylinositol 3-kinase (PI3K)-PtdIns(3,4,5)P(3)-protein kinase B (PKB/Akt) signaling pathway. It has long been thought that the lipid phosphatases SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 act as tumor suppressors by counteracting with the survival signal induced by this pathway through hydrolysis or PtdIns(3,4,...

full text

The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.

Fc gammaRIIB are single-chain low-affinity receptors for IgG that bear an immunoreceptor tyrosine-based inhibition motif (ITIM) in their intracytoplasmic domain and that negatively regulate immunoreceptor tyrosine-based activation motif (ITAM)-dependent cell activation. In B cells, coaggregation of the B cell receptor (BCR) and Fc gammaRIIB leads to an inhibition of B cell activation. Inhibitor...

full text

Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome.

Type II SH2 domain-containing inositol 5-phosphatase (INPPL1, or SHIP2) plays an important role in the control of insulin sensitivity. INPPL1 mutations affecting gene function have been found in rat models of type 2 diabetes and hypertension and in type 2 diabetic patients. We investigated the influence of nucleotide variation in INPPL1 on components of the metabolic syndrome. Following compreh...

full text

The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin

SHIP-2 is a phosphoinositidylinositol 3,4,5 trisphosphate (PtdIns[3,4,5]P3) 5-phosphatase that contains an NH2-terminal SH2 domain, a central 5-phosphatase domain, and a COOH-terminal proline-rich domain. SHIP-2 negatively regulates insulin signaling. In unstimulated cells, SHIP-2 localized in a perinuclear cytosolic distribution and at the leading edge of the cell. Endogenous and recombinant S...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue None

pages  31- 38

publication date 2015-06

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023